Your request to link to rcsb for Arginase-1

• 1D3V: crystal structure of the binuclear manganese metalloenzyme arginase complexed with 2(s)-amino-6-boronohexanoic acid, an l-arginine analog (10.1038/14929 )
• 1HQ5: crystal structure of the binuclear manganese metalloenzyme arginase complexed with s-(2-boronoethyl)-l-cysteine, an l-arginine analogue (10.1021/BI002317H )
• 1HQF: crystal structure of the binuclear manganese metalloenzyme arginase complexed with n-hydroxy-l-arginine (10.1021/BI002318+ )
• 1HQH: crystal structure of the binuclear manganese metalloenzyme arginase complexed with nor-n-hydroxy-l-arginine (10.1021/BI002318+ )
• 1R1O: amino acid sulfonamides as transition-state analogue inhibitors of arginase (10.1021/JA036365B )
• 1RLA: three-dimensional structure of rat liver arginase, the binuclear manganese metalloenzyme of the urea cycle (10.1038/383554A0 )
• 1WVA: crystal structure of human arginase i from twinned crystal (10.1073/PNAS.0504027102 )
• 1WVB: crystal structure of human arginase i: the mutant e256q
• 2AEB: crystal structure of human arginase i at 1.29 a resolution and exploration of inhibition in immune response. (10.1073/PNAS.0504027102 )
• 2PHA: crystal structure of native, unliganded human arginase at 1.90 resolution (10.1021/JA071567J )
• 2PHO: crystal structure of human arginase i complexed with thiosemicarbazide at 1.95 resolution (10.1021/JA071567J )
• 2PLL: crystal structure of perdeuterated human arginase i (10.1016/J.ABB.2007.04.036 )
• 2ZAV: arginase i (homo sapiens): native and unliganded structure at 1.70 a resolution (10.1021/JA071567J )
• 3DJ8: synthesis of (2s)-2-amino-7,8-epoxyoctanoic acid and structure of its metal-bridging complex with human arginase i 25-aug-09 3dj8 1 hetsyn title (10.1039/B811797G )
• 3E6K: x-ray structure of human arginase i: the mutant d183a in complex with abh (10.1021/BI801911V )
• 3E6V: x-ray structure of human arginase i-d183n mutant: the complex with abh (10.1021/BI801911V )
• 3F80: (s)-2-amino-6-nitrohexanoic acid binds to human arginase i through multiple nitro-metal coordination interactions in the binuclear manganese cluster. resolution 1.60 a. (10.1021/JA807702Q )
• 3GMZ: crystal of human arginase in complex with l-ornithine. resolution 1.43 a. (10.1021/JM200443B )
• 3GN0: crystal structure of human arginase i in complex with difluoromethylornithine (dfmo) (10.1021/JM200443B )
• 3KV2: high resolution structure of human arginase i in complex with the strong inhibitor n(omega)-hydroxy-nor-l-arginine (nor-noha) (10.1016/J.ABB.2010.02.004 )
• 3LP4: crystal structure of human arginase i in complex with l-lysine, 1.90a resolution. (10.1016/J.ABB.2010.02.004 )
• 3LP7: crystal structure of human arginase i in complex with inhibitor n(omega)-hydroxy-l-arginine (noha), 2.04a resolution (10.1016/J.ABB.2010.02.004 )
• 3MFV: crystal structure of human arginase i in complex with 2- aminohomohistidine (10.1021/JM100306A )
• 3MFW: crystal structure of human arginase i in complex with l-2- aminohistidine and sulphate (10.1021/JM100306A )
• 3MJL: crystal structure of human arginase i in complex with 2- aminoimidazole. resolution 1.90 a.
• 3SJT: crystal structure of human arginase i in complex with the inhibitor me-abh, resolution 1.60 a, twinned structure (10.1021/JM200443B )
• 3SKK: crystal structure of human arginase i in complex with the inhibitor fabh, resolution 1.70 a, twinned structure (10.1021/JM200443B )
• 3TF3: crystal structure of metal-free human arginase i (10.1021/BI201101T )
• 3TH7: crystal structure of unliganded co2+2-hai (ph 7.0) (10.1021/BI201101T )
• 3THE: crystal structure of co2+2-hai (ph 8.5) (10.1021/BI201101T )
• 3THH: crystal structure of the co2+2-hai-abh complex (10.1021/BI201101T )
• 3THJ: crystal structure of the co2+2-hai-l-orn complex (10.1021/BI201101T )
• 4FCI: crystal structure of the mn2+2-human arginase i-agpa complex (10.1107/S1744309112027820 )
• 4FCK: crystal structure of the co2+2-human arginase i-agpa complex (10.1107/S1744309112027820 )
• 4GSM: crystal structure of ni2+2-human arginase i (10.1021/BI301145N )
• 4GSV: crystal structure of the ni2+2-human arginase i-abh complex (10.1021/BI301145N )
• 4GSZ: crystal structure of the zn2+5-human arginase i-abh complex (10.1021/BI301145N )
• 4GWC: crystal structure of mn2+2,zn2+-human arginase i (10.1021/BI301145N )
• 4GWD: crystal structure of the mn2+2,zn2+-human arginase i-abh complex (10.1021/BI301145N )
• 4HWW: crystal structure of human arginase-1 complexed with inhibitor 9 (10.1021/JM400014C )
• 4HXQ: crystal structure of human arginase-1 complexed with inhibitor 14 (10.1021/JM400014C )
• 4IE1: crystal structure of human arginase-1 complexed with inhibitor 1h (10.1016/J.BMCL.2013.02.024 )
• 6Q92: crystal structure of human arginase-1 at ph 7.0 in complex with abh (10.1016/J.YJSBX.2019.100014 )
• 6Q9P: crystal structure of human arginase-1 at ph 9.0 in complex with abh (10.1016/J.YJSBX.2019.100014 )
• 6QAF: crystal structure of human arginase-1 at ph 9.0 in complex with cb- 1158/incb001158 (10.1016/J.YJSBX.2019.100014 )
• 6V7C: human arginase1 complexed with bicyclic inhibitor compound 3 (10.1021/ACSMEDCHEMLETT.0C00058 )
• 6V7D: human arginase1 complexed with bicyclic inhibitor compound 10 (10.1021/ACSMEDCHEMLETT.0C00058 )
• 6V7E: human arginase1 complexed with bicyclic inhibitor compound 12 (10.1021/ACSMEDCHEMLETT.0C00058 )
• 6V7F: human arginase1 complexed with bicyclic inhibitor compound 13 (10.1021/ACSMEDCHEMLETT.0C00058 )
• 7K4G: human arginase 1 in complex with compound 01. (10.1021/ACSMEDCHEMLETT.1C00258 )
• 7K4H: human arginase 1 in complex with compound 04. (10.1021/ACSMEDCHEMLETT.1C00258 )
• 7K4I: human arginase 1 in complex with compound 06. (10.1021/ACSMEDCHEMLETT.1C00258 )
• 7K4J: human arginase 1 in complex with compound 51. (10.1021/ACSMEDCHEMLETT.1C00258 )
• 7K4K: human arginase 1 in complex with compound 52. (10.1021/ACSMEDCHEMLETT.1C00258 )
• 7KLK: human arginase1 complexed with inhibitor compound 3a (10.1021/ACSMEDCHEMLETT.1C00195 )
• 7KLL: human arginase1 complexed with inhibitor compound 18 (10.1021/ACSMEDCHEMLETT.1C00195 )
• 7KLM: human arginase1 complexed with inhibitor compound 24a (10.1021/ACSMEDCHEMLETT.1C00195 )
• 7LEX: trimeric human arginase 1 in complex with mab1 - 2 harg:3 mab1 complex (10.1038/S42003-021-02444-Z )
• 7LEY: trimeric human arginase 1 in complex with mab5 (10.1038/S42003-021-02444-Z )
• 7LEZ: trimeric human arginase 1 in complex with mab1 - 2 harg:2 mab1 complex (10.1038/S42003-021-02444-Z )
• 7LF0: trimeric human arginase 1 in complex with mab2 (10.1038/S42003-021-02444-Z )
• 7LF1: trimeric human arginase 1 in complex with mab3 (10.1038/S42003-021-02444-Z )
• 7LF2: trimeric human arginase 1 in complex with mab4 (10.1038/S42003-021-02444-Z )